For citations:
Ivashkin V.T., Maslennikov R.V., Vasilieva E.V., Chipurik M.L., Semikova P.A., Semenets V.V., Russkova T.A. Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(5):54-64. https://doi.org/10.22416/1382-4376-2023-33-5-54-64
Views PDF (Eng): 76